Krystexxa 8MG/ML
Ended Awarded
- Contract number
- 36C24220N0479
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $65,686
Award facts
- Contract value 100% obligated
- $65,686.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Syracuse, NY 13210, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $65,686.15 firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Horizon Therapeutics USA Inc. under the company's $25 million Multiple Award Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order is for KRYSTEXXA 8MG/ML, a specialty pharmaceutical used to treat chronic gout. Horizon Therapeutics is a global biotechnology firm that provides critical medications to support healthcare services for veterans through the VA's Veterans Health Administration (VHA). This delivery order does not have a set-aside designation, and Horizon is the prime contractor with no major subcontractors noted. The order was placed by the VA's Veterans Integrated Service Network 2 (VISN 2) to acquire this specialty drug for use at VA medical facilities in the upstate New York region.
Quick answers
Who was awarded contract 36C24220N0479?
36C24220N0479 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on April 8, 2020.
How much is contract 36C24220N0479 worth?
The government has obligated $65,686 on 36C24220N0479.
Is contract 36C24220N0479 an order under another contract?
Yes. 36C24220N0479 is a BPA call under 36F79719D0224-36E79719A0032, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24220N0479 competed?
The extent of competition for 36C24220N0479 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award